SYP-5 is primarily used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors. It plays a significant role in medicinal chemistry due to its ability to selectively bind to specific enzyme targets involved in cellular signaling pathways. This makes it valuable in the research and development of targeted cancer therapies. Its structure allows for easy functionalization, enabling chemists to modify and optimize drug candidates for improved potency, selectivity, and pharmacokinetic properties. SYP-5 is also employed in early-stage drug discovery for high-throughput screening and structure-activity relationship (SAR) studies.